| 2026-08-13 | Press release | Dyadic International, Inc. Secures $2.9 Million Through Registered Direct Offering and Concurrent Private Placement |
| 2026-08-12 | Press release | Dyadic Announces Second Quarter 2026 Financial Results Accelerating Commercialization Momentum Across Key Business Areas |
| 2026-08-04 | Press release | Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement |
| 2026-08-03 | Press release | Dyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026 |
| 2026-07-28 | Press release | Dyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in A |
| 2026-07-24 | Press release | Dyadic Announces Continued Listing on the Nasdaq Capital Market |
| 2026-07-16 | Press release | Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program |
| 2026-07-07 | Press release | Global Collaborations Continue to Validate Dyadic’s C1 Platform and Expands Commercial Potential |
| 2026-06-29 | Press release | Dyadic Expands IP Protection and Business Development Activities in Japan |
| 2026-06-15 | Press release | Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Co |
| 2026-05-28 | Press release | Dyadic and Scripps Research Collaborate on Rapid-Response Hantavirus Antibody and Vaccine Development |
| 2026-05-21 | Press release | Dyadic to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 |
| 2026-05-19 | Press release | Dyadic Applied BioSolutions Announces Participation in Sidoti Virtual Investor Conference |
| 2026-05-13 | Press release | Dyadic Announces First Quarter 2026 Financial Results and Highlights Recent Company Progress |
| 2026-04-29 | Press release | Dyadic to Report Q1 2026 Financial Results and Host Conference Call on Wednesday May 13, 2026 |
| 2026-03-25 | Press release | Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress |
| 2026-03-16 | Press release | Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices |
| 2026-03-11 | Press release | Dyadic to Report 2025 Full Year Financial Results and Host Conference Call on Wednesday, March 25, 2026 |
| 2026-03-04 | Press release | Dyadic and Fermbox Bio Launch First Product Under Expanded Collaboration: Animal-Origin-Free Recombinant DNase I (RNase |
| 2026-03-02 | Press release | Dyadic Applied BioSolutions and Inzymes ApS Announce Planned 2026 Commercialization of Non-Animal Dairy Enzyme Following |
| 2026-02-17 | Press release | Dyadic Applied BioSolutions and Proliant Health & Biologicals Announce Commercial Launch of Recombinant Human Albumi |